Merck On A Mission To Introduce Automation To Fertility Treatment
Healthcare giant Merck is on a mission to introduce automation to fertility treatment and improve patient outcomes. The German company, already a leader in fertility drugs, aims to expand its market position by delivering innovative device technologies.
You may also be interested in...
US regulators are proposing makers of fertility assistant devices first test their products on mice embryos in the lab to better understand any potential toxicity risk to human embryos and the viability of the fetus.
Proposals for averting medicines supply disruptions caused by Brexit in Northern Ireland and three EU markets are about to be discussed by EU legislators.
Denying any wrongdoing or admission of liability, Teva has agreed to a proposed settlement of $420m with a class of investors following allegations that the firm had concealed the true nature of its increase in profits, which artificially inflated the price of Teva’s securities.